Acadia Pharmaceuticals ACAD
NASDAQ ACAD
$20.31 +0.12 (+0.59%)
At close: Oct 22, 2026 · 4:00 PM EDT

Acadia Pharmaceuticals (ACAD) Accumulated Expenses (2010 - 2026)

Updated

Acadia Pharmaceuticals (ACAD) posted Accumulated Expenses of $316.87 million for Q2 2026, up 2.2% from $309.93 million a year earlier and up 8.0% from the prior quarter.

Analysis

Acadia Pharmaceuticals (ACAD) Accumulated Expenses (2010 - 2026) Analysis & Trends

At the end of FY2025, Acadia Pharmaceuticals' Accumulated Expenses came in at $266.21 million, down 29.7% from FY2024.

  • Annual Accumulated Expenses shows a five-year compound annual growth rate of 22.3% (FY2020 to FY2025).
  • In prior years, Acadia Pharmaceuticals' Accumulated Expenses was $378.68 million in FY2024 (+60.0%), $236.71 million in FY2023 (+109.7%), $112.88 million in FY2022 (+26.6%) and $89.19 million in FY2021 (-8.5%).
  • Quarterly Accumulated Expenses has run from a low of $80.5 million in Q3 2021 to a high of $378.68 million in Q4 2024 over five years.
  • On a year-over-year basis, Accumulated Expenses increased in five of the last eight quarters, with growth averaging 11.5%.
  • The strongest year-over-year quarter for Accumulated Expenses in the past five years was Q4 2023, with growth of 109.7%; the weakest was Q4 2025, with a decline of 29.7%.
  • According to Business Quant data, Accumulated Expenses for the three prior quarters was $293.28 million (Q1 2026), $266.21 million (Q4 2025) and $334.84 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Acadia Pharmaceuticals 3.48 Bn 2.04 Mn 279.64 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 316.87 Mn
Mar 31, 2026 293.28 Mn
Dec 31, 2025 266.21 Mn
Sep 30, 2025 334.84 Mn
Jun 30, 2025 309.93 Mn
Mar 31, 2025 284.44 Mn
Dec 31, 2024 378.68 Mn
Sep 30, 2024 324.86 Mn
Jun 30, 2024 317.97 Mn
Mar 31, 2024 311.27 Mn
Dec 31, 2023 236.71 Mn
Sep 30, 2023 197.29 Mn
Jun 30, 2023 169.13 Mn
Mar 31, 2023 206.88 Mn
Dec 31, 2022 112.88 Mn
Sep 30, 2022 106.56 Mn
Jun 30, 2022 105.83 Mn
Mar 31, 2022 108.84 Mn
Dec 31, 2021 89.19 Mn
Sep 30, 2021 80.50 Mn
API Access

Acadia Pharmaceuticals Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ACAD&period=max&api_key=YOUR_API_KEY